Bioavailability of Zinc and Iron From a Whey-based Protein Supplement Consumed With a Habitual Plant-based Diet

NCT02208622 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-07-05

No results posted yet for this study

Summary

Bioavailability of iron and zinc from habitual plant-based diets consumed by young children in Mexico is low due to the high phytate content. Whey protein has been found to increase zinc absorption, thus, providing a whey based supplement with micronutrients may be an effective strategy to increase iron and zinc bioavailability from plant-based foods and alleviate iron and zinc deficiencies. The investigators compared absorption of zinc and iron in children receiving diets with and without whey protein supplements (WPS).

Conditions

  • Nutritional Deficiency

Interventions

DIETARY_SUPPLEMENT

Study 1: Whey Supplement Day 1

Whey supplement was given on day 1, control diet on day 2

DIETARY_SUPPLEMENT

Study 1: Whey Supplement Day 2

Control diet was given day 1, whey supplement was given day 2

DIETARY_SUPPLEMENT

Study 2: Whey Supplement

Whey supplement was given as part of diet for both day 1 and 2 of study

Sponsors & Collaborators

  • Universidad Autonoma de Queretaro

    collaborator OTHER
  • International Atomic Energy Agency

    collaborator OTHER_GOV
  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Michael Hambidge, MD · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
2 Years
Max Age
3 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States
  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02208622 on ClinicalTrials.gov